Status:
COMPLETED
The CASPER Registry
Lead Sponsor:
University of Pisa
Conditions:
Bicuspid Aortic Valve
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The CASPER study is a prospective, international, multicenter registry which aims to evaluate the use of an algorithm for choosing the size of the prosthesis to be implanted in patients with bicuspid ...
Detailed Description
STUDY DESIGN This is an Investigator initiated, international, multicenter, prospective registry, enrolling 100 consecutive BAV patients who will undergo TAVI with the Evolut R/Pro (23-26-29)/Evolut ...
Eligibility Criteria
Inclusion
- Age ≥18 years.
- NYHA≥2 and/or syncope and/or angina.
- Patient judged by the Heart Team as indicated for TAVI.
- Anatomical suitability for transfemoral or any alternative access TAVI, based on MSCT assessment and local expertise and preference.
- Estimated life expectancy\>1 year.
Exclusion
- Age \<18 years
- Estimated life expectancy\<1 year
- Pure aortic regurgitation.
- LVEF\<20%
- No baseline MSCT evaluation.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04817735
Start Date
July 1 2021
End Date
December 31 2024
Last Update
January 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy, 56124